To explore the anti-obesity mechanisms, the liver LepRb, JAK2, and STAT3 expressions in the leptin metabolic JAK2-STAT3 signaling pathway were evaluated by Western blotting, which suggested an improved leptin-resistant state via activating the JAK2-STAT3 signaling pathway. The gene discussed is JAK2; the disease is obesity disorder.